The HALT Biomarker Study

Clinical trial NCT04552275 · RECRUITING

Trial details

NCT number: NCT04552275
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Aortic Stenosis Hypo-attenuated Leaflet Thickening Bioprosthetic Valve Degeneration

Start date: 2020-06-22
Primary completion: 2030-06-22
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.